産業排出ガス中並びに室内空気中の微粒子除去用電気集塵装置の研究

学位の種別: 論文博士審査委員会委員 : (主査)東京大学准教授 小野 亮, 東京大学教授 日髙 邦彦, 東京大学教授 小野 靖, 東京大学准教授 熊田 亜紀子, 豊橋技術科学大学教授 水野 彰, 東京大学名誉教授 小田 哲治University of Tokyo(東京大学

Influence of welding passes on grain orientation - The example of a multi-pass V-weld

International audienceThe accurate modelling of grain orientations in a weld is important, when accurate ultrasonic test predictions of a welded assembly are needed. To achieve this objective, Electricité de France (EDF) and the Laboratoire de Caractérisation Non Destructive (LCND) have developed a dedicated code, which makes use of information recorded in the welding procedure. Among the welding parameters recorded, although the order in which the welding passes are made is of primary importance in the welding process, this information is not always well known or accurately described. In the present paper we analyse in greater detail the influence of the order of welding passes, using data obtained from the Centre for Advanced Non Destructive Evaluation (CANDE), derived from a dissimilar metal weld (DMW) with buttering. Comparisons are made using grain orientation measurements on a macrograph

Observation of orientation-dependent photovoltaic behaviors in aligned organic nanowires

We fabricated organic nanowire (NW) solar cells based on aligned NWs of n-channel organic semiconductor, N,N???-bis(2-phenylethyl)-perylene-3,4:9, 10-tetracarboxylic diimide via a filtration-and-transfer alignment method. It is well known that most efficient charge transport typically takes place along the long axis of organic NWs. However, there is no systematic study on the correlation between the orientation of NWs in the active layer and the power conversion efficiency (PCE) of solar cells. Our results demonstrate the effects of alignment direction of NWs on the PCE of organic solar cells with single-crystalline NWs.open0

Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker

<p>Abstract</p> <p>Background</p> <p>Breast cancer is one of the leading causes of women's death worldwide. It is important to discover a reliable biomarker for the detection of breast cancer. Plasma is the most ideal source for cancer biomarker discovery since many cells cross-communicate through the secretion of soluble proteins into blood.</p> <p>Methods</p> <p>Plasma proteomes obtained from 6 breast cancer patients and 6 normal healthy women were analyzed by using the isotope-coded affinity tag (ICAT) labeling approach and tandem mass spectrometry. All the plasma samples used were depleted of highly abundant 6 plasma proteins by immune-affinity column chromatography before ICAT labeling. Several proteins showing differential abundance level were selected based on literature searches and their specificity to the commercially available antibodies, and then verified by immunoblot assays.</p> <p>Results</p> <p>A total of 155 proteins were identified and quantified by ICAT method. Among them, 33 proteins showed abundance changes by more than 1.5-fold between the plasmas of breast cancer patients and healthy women. We chose 5 proteins for the follow-up confirmation in the individual plasma samples using immunoblot assay. Four proteins, α1-acid glycoprotein 2, monocyte differentiation antigen CD14, biotinidase (BTD), and glutathione peroxidase 3, showed similar abundance ratio to ICAT result. Using a blind set of plasmas obtained from 21 breast cancer patients and 21 normal healthy controls, we confirmed that BTD was significantly down-regulated in breast cancer plasma (Wilcoxon rank-sum test, <it>p </it>= 0.002). BTD levels were lowered in all cancer grades (I-IV) except cancer grade zero. The area under the receiver operating characteristic curve of BTD was 0.78. Estrogen receptor status (<it>p </it>= 0.940) and progesterone receptor status (<it>p </it>= 0.440) were not associated with the plasma BTD levels.</p> <p>Conclusions</p> <p>Our study suggests that BTD is a potential serological biomarker for the detection of breast cancer.</p